Peptide Library

Research statistics

Desmopressin research: publications and trials

What has been published on Desmopressin: PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether Desmopressin works or is safe. For what it is and what the studies found, see the Desmopressin profile.
Automated weekly refresh · data through November 1, 2026

At a glance

Publications, all years

3,764

Since 1972

Publications in 2026 so far

111

Through November 1, 2026

Human clinical research

60.2%

2,153 of 3,574 classified

Registered clinical trials

103

ClinicalTrials.gov

Randomized controlled trials

318

Publications reporting an RCT in people

Systematic reviews and meta-analyses

90

Preclinical studies

22.2%

642 animal · 140 in vitro · 11 computational

Records that only mention it

2,105

Not counted above

Status in the library: FDA-approved. 190 publications are not yet classified by study type.

What to keep in mind

  • Some completed trials have neither posted results nor a linked results publication.

Publications by year

Desmopressin publications by year and evidence

1972, Human clinical research: 1 of 11973, Human clinical research: 1 of 31973, Other and not yet classified: 2 of 31974, Human clinical research: 2 of 101974, Preclinical (animal, in vitro, computational): 1 of 101974, Other and not yet classified: 7 of 101975, Human clinical research: 9 of 121975, Other and not yet classified: 3 of 121976, Human clinical research: 12 of 171976, Preclinical (animal, in vitro, computational): 1 of 171976, Other and not yet classified: 4 of 171977, Human clinical research: 9 of 151977, Preclinical (animal, in vitro, computational): 1 of 151977, Other and not yet classified: 5 of 151978, Human clinical research: 14 of 271978, Preclinical (animal, in vitro, computational): 2 of 271978, Other and not yet classified: 11 of 271979, Human clinical research: 14 of 311979, Preclinical (animal, in vitro, computational): 2 of 311979, Other and not yet classified: 15 of 311980, Human clinical research: 14 of 321980, Preclinical (animal, in vitro, computational): 7 of 321980, Other and not yet classified: 11 of 321981, Human clinical research: 18 of 351981, Preclinical (animal, in vitro, computational): 7 of 351981, Other and not yet classified: 10 of 351982, Human clinical research: 21 of 481982, Preclinical (animal, in vitro, computational): 16 of 481982, Other and not yet classified: 11 of 481983, Human clinical research: 21 of 481983, Preclinical (animal, in vitro, computational): 16 of 481983, Reviews and meta-analyses: 1 of 481983, Other and not yet classified: 10 of 481984, Human clinical research: 29 of 621984, Preclinical (animal, in vitro, computational): 15 of 621984, Other and not yet classified: 18 of 621985, Human clinical research: 25 of 601985, Preclinical (animal, in vitro, computational): 18 of 601985, Reviews and meta-analyses: 1 of 601985, Other and not yet classified: 16 of 601986, Human clinical research: 40 of 691986, Preclinical (animal, in vitro, computational): 18 of 691986, Reviews and meta-analyses: 1 of 691986, Other and not yet classified: 10 of 691987, Human clinical research: 35 of 561987, Preclinical (animal, in vitro, computational): 16 of 561987, Reviews and meta-analyses: 1 of 561987, Other and not yet classified: 4 of 561988, Human clinical research: 41 of 831988, Preclinical (animal, in vitro, computational): 19 of 831988, Reviews and meta-analyses: 2 of 831988, Other and not yet classified: 21 of 831989, Human clinical research: 44 of 801989, Preclinical (animal, in vitro, computational): 15 of 801989, Reviews and meta-analyses: 5 of 801989, Other and not yet classified: 16 of 801990, Human clinical research: 51 of 1001990, Preclinical (animal, in vitro, computational): 26 of 1001990, Reviews and meta-analyses: 10 of 1001990, Other and not yet classified: 13 of 1001991, Human clinical research: 47 of 821991, Preclinical (animal, in vitro, computational): 17 of 821991, Reviews and meta-analyses: 7 of 821991, Other and not yet classified: 11 of 821992, Human clinical research: 39 of 801992, Preclinical (animal, in vitro, computational): 21 of 801992, Reviews and meta-analyses: 4 of 801992, Other and not yet classified: 16 of 801993, Human clinical research: 48 of 921993, Preclinical (animal, in vitro, computational): 24 of 921993, Reviews and meta-analyses: 10 of 921993, Other and not yet classified: 10 of 921994, Human clinical research: 35 of 751994, Preclinical (animal, in vitro, computational): 24 of 751994, Reviews and meta-analyses: 9 of 751994, Other and not yet classified: 7 of 751995, Human clinical research: 47 of 871995, Preclinical (animal, in vitro, computational): 20 of 871995, Reviews and meta-analyses: 7 of 871995, Other and not yet classified: 13 of 871996, Human clinical research: 38 of 771996, Preclinical (animal, in vitro, computational): 24 of 771996, Reviews and meta-analyses: 7 of 771996, Other and not yet classified: 8 of 771997, Human clinical research: 55 of 931997, Preclinical (animal, in vitro, computational): 17 of 931997, Reviews and meta-analyses: 10 of 931997, Other and not yet classified: 11 of 931998, Human clinical research: 48 of 821998, Preclinical (animal, in vitro, computational): 21 of 821998, Reviews and meta-analyses: 9 of 821998, Other and not yet classified: 4 of 821999, Human clinical research: 55 of 911999, Preclinical (animal, in vitro, computational): 25 of 911999, Reviews and meta-analyses: 5 of 911999, Other and not yet classified: 6 of 912000, Human clinical research: 40 of 662000, Preclinical (animal, in vitro, computational): 17 of 662000, Reviews and meta-analyses: 8 of 662000, Other and not yet classified: 1 of 662001, Human clinical research: 49 of 752001, Preclinical (animal, in vitro, computational): 16 of 752001, Reviews and meta-analyses: 10 of 752002, Human clinical research: 45 of 752002, Preclinical (animal, in vitro, computational): 17 of 752002, Reviews and meta-analyses: 8 of 752002, Other and not yet classified: 5 of 752003, Human clinical research: 40 of 722003, Preclinical (animal, in vitro, computational): 18 of 722003, Reviews and meta-analyses: 5 of 722003, Other and not yet classified: 9 of 722004, Human clinical research: 57 of 892004, Preclinical (animal, in vitro, computational): 20 of 892004, Reviews and meta-analyses: 11 of 892004, Other and not yet classified: 1 of 892005, Human clinical research: 48 of 762005, Preclinical (animal, in vitro, computational): 17 of 762005, Reviews and meta-analyses: 8 of 762005, Other and not yet classified: 3 of 762006, Human clinical research: 37 of 692006, Preclinical (animal, in vitro, computational): 17 of 692006, Reviews and meta-analyses: 12 of 692006, Other and not yet classified: 3 of 692007, Human clinical research: 56 of 882007, Preclinical (animal, in vitro, computational): 16 of 882007, Reviews and meta-analyses: 13 of 882007, Other and not yet classified: 3 of 882008, Human clinical research: 41 of 712008, Preclinical (animal, in vitro, computational): 19 of 712008, Reviews and meta-analyses: 8 of 712008, Other and not yet classified: 3 of 712009, Human clinical research: 39 of 642009, Preclinical (animal, in vitro, computational): 14 of 642009, Reviews and meta-analyses: 7 of 642009, Other and not yet classified: 4 of 642010, Human clinical research: 49 of 842010, Preclinical (animal, in vitro, computational): 20 of 842010, Reviews and meta-analyses: 12 of 842010, Other and not yet classified: 3 of 842011, Human clinical research: 55 of 852011, Preclinical (animal, in vitro, computational): 13 of 852011, Reviews and meta-analyses: 12 of 852011, Other and not yet classified: 5 of 852012, Human clinical research: 38 of 722012, Preclinical (animal, in vitro, computational): 18 of 722012, Reviews and meta-analyses: 9 of 722012, Other and not yet classified: 7 of 722013, Human clinical research: 49 of 952013, Preclinical (animal, in vitro, computational): 22 of 952013, Reviews and meta-analyses: 17 of 952013, Other and not yet classified: 7 of 952014, Human clinical research: 55 of 872014, Preclinical (animal, in vitro, computational): 20 of 872014, Reviews and meta-analyses: 9 of 872014, Other and not yet classified: 3 of 872015, Human clinical research: 43 of 712015, Preclinical (animal, in vitro, computational): 19 of 712015, Reviews and meta-analyses: 5 of 712015, Other and not yet classified: 4 of 712016, Human clinical research: 47 of 922016, Preclinical (animal, in vitro, computational): 23 of 922016, Reviews and meta-analyses: 14 of 922016, Other and not yet classified: 8 of 922017, Human clinical research: 41 of 722017, Preclinical (animal, in vitro, computational): 7 of 722017, Reviews and meta-analyses: 8 of 722017, Other and not yet classified: 16 of 722018, Human clinical research: 51 of 832018, Preclinical (animal, in vitro, computational): 11 of 832018, Reviews and meta-analyses: 15 of 832018, Other and not yet classified: 6 of 832019, Human clinical research: 39 of 662019, Preclinical (animal, in vitro, computational): 7 of 662019, Reviews and meta-analyses: 13 of 662019, Other and not yet classified: 7 of 662020, Human clinical research: 59 of 932020, Preclinical (animal, in vitro, computational): 12 of 932020, Reviews and meta-analyses: 12 of 932020, Other and not yet classified: 10 of 932021, Human clinical research: 59 of 922021, Preclinical (animal, in vitro, computational): 10 of 922021, Reviews and meta-analyses: 15 of 922021, Other and not yet classified: 8 of 922022, Human clinical research: 60 of 932022, Preclinical (animal, in vitro, computational): 16 of 932022, Reviews and meta-analyses: 12 of 932022, Other and not yet classified: 5 of 932023, Human clinical research: 55 of 922023, Preclinical (animal, in vitro, computational): 11 of 922023, Reviews and meta-analyses: 20 of 922023, Other and not yet classified: 6 of 922024, Human clinical research: 54 of 772024, Preclinical (animal, in vitro, computational): 13 of 772024, Reviews and meta-analyses: 8 of 772024, Other and not yet classified: 2 of 772025, Human clinical research: 63 of 1062025, Preclinical (animal, in vitro, computational): 12 of 1062025, Reviews and meta-analyses: 17 of 1062025, Other and not yet classified: 14 of 1062026 (to date), Human clinical research: 71 of 1112026 (to date), Preclinical (animal, in vitro, computational): 15 of 1112026 (to date), Reviews and meta-analyses: 13 of 1112026 (to date), Other and not yet classified: 12 of 111Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified050100150197219831994200520162026*
Counted PubMed publications by year of first publication. * 2026 runs to November 1, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
197210001
197310023
1974210710
1975900312
19761210417
1977910515
197814201127
197914201531
198014701132
198118701035
1982211601148
1983211611048
1984291501862
1985251811660
1986401811069
198735161456
1988411922183
1989441551680
199051261013100
1991471771182
1992392141680
19934824101092
199435249775
1995472071387
199638247877
19975517101193
199848219482
199955255691
200040178166
2001491610075
200245178575
200340185972
2004572011189
200548178376
2006371712369
2007561613388
200841198371
200939147464
2010492012384
2011551312585
201238189772
2013492217795
201455209387
201543195471
2016472314892
201741781672
2018511115683
201939713766
20205912121093
2021591015892
2022601612593
2023551120692
202454138277
202563121714106
2026 (to date)71151312111

Study types

Case report844
Animal study642
Other clinical trial546
Observational human study445
Randomized controlled trial318
Review300
Editorial, letter or other225
Not yet classified190
In vitro study140
Meta-analysis49
Systematic review41
Computational study11
Guideline or consensus9
Correction or retraction notice4

Research areas

From MeSH major topics. A paper can be in several areas.

Endocrinology1,217
Reproductive and sexual health1,210
Neurological and mental health1,092
Cardiovascular650
Metabolic health593
Tissue repair232
Immune system190
Oncology189
Gastrointestinal107
Musculoskeletal83
Antimicrobial and infectious disease64
Dermatology46

Registered clinical trials

26 of 57 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.

Completed: 60 · Unknown status: 19 · Terminated: 10 · Recruiting: 8 · Enrolling by invitation: 3 · Active, not recruiting: 1 · Not yet recruiting: 1 · Withdrawn: 1
Early phase 1: 1 · Phase not applicable: 36 · Phase 1: 5 · Phase 2: 14 · Phase 2 / Phase 3: 2 · Phase 3: 18 · Phase 4: 27

TrialStatusPhaseStartedResults
FESS With or Without Intranasal Desmopressin in Chronic Rhinosinusitis With Nasal PolypsNCT07855315 · 174 enrolledNot yet recruitingPhase not applicable2026-10—
Bedtime Device Restriction and Desmopressin in PMNE.NCT07776977 · 140 enrolledRecruitingPhase not applicable2026-08—
DDAVP Effect by TEG6 in Cardiac SurgeryNCT07179991 · 100 enrolledRecruitingPhase not applicable2026-08—
Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region TumorsNCT07712328 · 152 enrolledEnrolling by invitationPhase 42026-06—
DDAVP for Pituitary AdenomaNCT04569591 · 22 enrolledRecruitingPhase not applicable2026-03—
Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot TrialNCT06337838 · 100 enrolledRecruitingPhase 32025-06—
Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe HyponatremiaNCT06020495 · 260 enrolledRecruitingPhase 32024-12—
Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and Vitamin D DeficiencyNCT07292753 · 90 enrolledCompletedPhase not applicable2024-12—
Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing SyndromeNCT06635629 · 140 enrolledRecruitingPhase 22024-12—
Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNENCT07199894 · 120 enrolledRecruitingPhase 32024-12—
Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal EnuresisNCT06771128 · 398 enrolledCompletedPhase not applicable2024-11—
Bleeding Prevention With Desmopressin for Allograft Kidney BiopsiesNCT06622187 · 96 enrolledEnrolling by invitationPhase 42024-08—
Analysis of the Clinical Efficacy of Intravenous Application of Hemostatic Drugs in Improving the Clarity of Vision Under Endoscope, Perioperative Bleeding Volume and Anti-inflammatory Effect of Spinal Endoscopic Lumbar FusionNCT06255366 · 126 enrolledUnknown statusPhase 42024-03—
Desmopressin Monotherapy for Monosymptomatic Nocturnal EnuresisNCT06285006 · 50 enrolledUnknown statusPhase not applicable2024-02—
Ginko Biloba Versus Desmopressin in Treatment of Children With Monosymptomatic Nocturnal EnuresisNCT06772584 · 90 enrolledCompletedPhase not applicable2024-01—
International Multi-center Retrospective Study of Patients With Serum Sodium ≤110 mmol/L to Determine the Relationship Between Osmotic Demyelination Syndrome (ODS) and Rapid Correction of HyponatremiaNCT07576036 · 800 enrolledEnrolling by invitationPhase not applicable2023-11—
Adding Desmopressin to Tamsulosin for Treatment of BPHNCT05945420 · 160 enrolledUnknown statusPhase 42023-07—
Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.NCT06185361 · 60 enrolledUnknown statusPhase not applicable2022-12—
Mirabegron 25 mg for Treatment of Primary Nocturnal EnuresisNCT05617664 · 150 enrolledUnknown statusPhase not applicable2022-11—
Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of DesmopressinNCT05467033 · 424 enrolledRecruitingPhase 32022-09—
Nasal Desmopressin Versus Topical Epinephrine in Endonasal DacryocystorhinostomyNCT05507476 · 52 enrolledCompletedPhase not applicable2022-09—
Uroflowmetry and Nocturnal EnuresisNCT07028645 · 100 enrolledActive, not recruitingPhase not applicable2022-08—
Nasal Desmopressin Versus Oral Bisoprolol for Controlling Bleeding During Endoscopic Sinus SurgeryNCT05430048 · 100 enrolledCompletedPhase 22022-07—
Effect of Laser Acupuncture for Treating Monosymptomatic Nocturnal Enuresis in Adolescent FemalesNCT05399173 · 60 enrolledUnknown statusPhase not applicable2022-06—
Decline in Renal Concentration Ability in Lithium Treated PatientsNCT05307042 · 51 enrolledUnknown statusPhase not applicable2022-05—
Genetic Factors of the Desmopressin Response in Carriers of Hemophilia ANCT06020456 · 361 enrolledCompletedPhase not applicable2022-01—
NOCDURNA PASS Study Using Registries in Denmark, Germany and SwedenNCT04740645 · 1,099,551 enrolledCompletedPhase not applicable2021-07—
the Effect of Oral Vasopressors for Liberation From IV Vasopressors in Spinal ShockNCT04586790 · 90 enrolledUnknown statusPhase 22020-10—
Desmopressin for Bedwetting in Children With SCDNCT04420585 · 8 enrolledTerminatedPhase 42020-07Posted
Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia ANCT05628558 · 800 enrolledUnknown statusPhase not applicable2020-07—
Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)NCT04329975 · 1,087 enrolledCompletedPhase not applicable2020-05—
Posterior Tibial Nerve Stimulation Vs Desmopressin In Children With Primary Monosymptomatic Nocturnal EnuresisNCT04545931 · 80 enrolledUnknown statusPhase 42020-03—
A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal VolunteersNCT04103034 · 112 enrolledCompletedPhase 12019-10Posted
Safety and Tolerability Analysis of Combining Desmopressin With Docetaxel for the Treatment of Castration-Resistant Prostate CancerNCT04113005 · 10 enrolledUnknown statusEarly phase 12019-10—
Desmopressin for Reversal of Antiplatelet Drugs in Stroke Due to HaemorrhageNCT03696121 · 54 enrolledCompletedPhase 22019-04—
Study on Chinese and Western Medicine in MNE ChildrenNCT03733873 · 400 enrolledCompletedPhase not applicable2018-09—
To Evaluate the Renal Tubular Function Pre and Post Nephrectomy in Living DonorsNCT03676361WithdrawnPhase 42018-08—
Exercise Versus DDAVP in Patients With Mild Hemophilia ANCT03379974 · 32 enrolledCompletedPhase 42018-07—
The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings.NCT03389412 · 324 enrolledCompletedPhase 42017-10—
Prophylactic Desmopressin Before Native Kidney Biopsy in Severe Renal ImpairmentNCT07840313 · 250 enrolledCompletedPhase not applicable2017-08—
A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in AdultsNCT03201419 · 302 enrolledCompletedPhase 22017-07Posted
DDAVP vs. Exercise in Patients With Mild Hemophilia ANCT03136003 · 30 enrolledUnknown statusPhase 42017-07—
Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese SubjectsNCT03051009 · 503 enrolledCompletedPhase 32017-01—
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male SubjectsNCT02904759 · 342 enrolledCompletedPhase 32016-09—
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female SubjectsNCT02905682 · 190 enrolledCompletedPhase 32016-09—
Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric PopulationNCT02584231 · 25 enrolledCompletedPhase 42015-09—
Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell DiseaseNCT02636387 · 14 enrolledTerminatedPhase not applicable2015-08—
Study of Minirin Melt® in Adult Patients With NocturiaNCT03089073 · 835 enrolledTerminatedPhase not applicable2015-07—
Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and OlderNCT02262936 · 4 enrolledTerminatedPhase 2, Phase 32015-07—
Characterization of Laboratory Response to DDAVP in Adult Hemophilia A CarriersNCT02506023 · 2 enrolledCompletedPhase 12015-07—

The 50 most recently started of 103 trials.

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. Proactive desmopressin for the prevention of serum sodium overcorrection in moderate-to-severe hyponatremia: a systematic review and meta-analysis.

    BMC nephrology · June 25, 2026 · Meta-analysis · cited 0 times · open access

    PMID 42351030 · DOI 10.1186/s12882-026-05128-0 · Reviews and meta-analyses

  2. Effect of Preprocedural Desmopressin on Complications after Kidney Biopsy: A Systematic Review and Meta-Analysis.

    Kidney360 · March 12, 2026 · Meta-analysis · cited 0 times · open access

    PMID 41817599 · DOI 10.34067/kid.0000001185 · Reviews and meta-analyses

  3. Effectiveness of Bleeding Control Methods in Rhinoplasty: A Systematic Review and Meta-Analysis.

    Archives of plastic surgery · January 30, 2026 · Meta-analysis · cited 1 times · open access

    PMID 41625397 · DOI 10.1055/a-2706-1208 · Reviews and meta-analyses

  4. Efficacy of Desmopressin for Post-Kidney Biopsy Bleeding Complications Prevention: A Systematic Review With Frequentist and Bayesian Meta-Analysis.

    Nephrology (Carlton, Vic.) · January 1, 2026 · Meta-analysis · cited 0 times · open access

    PMID 41531175 · DOI 10.1111/nep.70164 · Reviews and meta-analyses

  5. Effect of desmopressin on bleeding outcomes after native renal biopsy: a systematic review and meta-analysis.

    Scientific reports · November 7, 2025 · Meta-analysis · cited 0 times · open access

    PMID 41203719 · DOI 10.1038/s41598-025-24092-7 · Reviews and meta-analyses

  6. Desmopressin and bleeding risk in high-risk native kidney biopsy: updated meta-analysis of RCTs and observational studies.

    Renal failure · August 31, 2025 · Meta-analysis · cited 3 times · open access

    PMID 40887459 · DOI 10.1080/0886022x.2025.2549775 · Reviews and meta-analyses

  7. Desmopressin for nocturnal enuresis in children.

    The Cochrane database of systematic reviews · July 29, 2025 · Meta-analysis · cited 6 times · open access

    PMID 40728007 · DOI 10.1002/14651858.cd002112.pub2 · Reviews and meta-analyses

  8. Efficacy and Safety of Desmopressin in Terms of Bleeding and Transfusion in Cardiac Surgery With Cardiopulmonary Bypass: A Systematic Review and Meta-Analysis.

    Heart, lung & circulation · June 4, 2025 · Meta-analysis · cited 5 times · open access

    PMID 40473511 · DOI 10.1016/j.hlc.2025.01.003 · Reviews and meta-analyses

  9. Preoperative Desmopressin for Bleeding Reduction During Rhinoplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

    Aesthetic plastic surgery · June 2, 2025 · Meta-analysis · cited 3 times

    PMID 40456991 · DOI 10.1007/s00266-025-04916-7 · Reviews and meta-analyses

  10. DDAVP response and its determinants in bleeding disorders: a systematic review and meta-analysis.

    Blood · April 1, 2025 · Meta-analysis · cited 9 times · open access

    PMID 39854691 · DOI 10.1182/blood.2024026804 · Reviews and meta-analyses

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. The use of DDAVP in children with bleeding disorders.

    Pediatric blood & cancer · October 25, 2012 · Review · cited 3,508 times

    PMID 23109357 · DOI 10.1002/pbc.24335 · Reviews and meta-analyses

  2. Abnormal osmotic regulation in trpv4-/- mice.

    Proceedings of the National Academy of Sciences of the United States of America · October 27, 2003 · Animal study · cited 797 times · open access

    PMID 14581612 · DOI 10.1073/pnas.1735416100 · Animal studies

  3. 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases.

    Lancet (London, England) · April 1, 1977 · Other clinical trial · cited 609 times

    PMID 67283 · DOI 10.1016/s0140-6736(77)91197-7 · Human clinical research

  4. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.

    The New England journal of medicine · January 1, 1983 · Randomized controlled trial · cited 607 times

    PMID 6401193 · DOI 10.1056/nejm198301063080102 · Human clinical research

  5. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.

    Lancet (London, England) · December 1, 1999 · Meta-analysis · cited 545 times

    PMID 10622296 · DOI 10.1016/s0140-6736(99)01264-7 · Reviews and meta-analyses

Latest publications

  1. Thromboembolic risk associated with desmopressin use in patients with central diabetes insipidus.

    European journal of internal medicine · October 27, 2026 · Editorial, letter or other · cited 0 times

    PMID 42946621 · DOI 10.1016/j.ejim.2026.107260 · Commentary and other

  2. Acute colonic pseudo-obstruction with transient failure of oral desmopressin in adipsic arginine vasopressin deficiency.

    JCEM case reports · October 27, 2026 · Case report · cited 0 times · open access

    PMID 42948338 · DOI 10.1210/jcemcr/luag334 · Human clinical research

  3. Author's Reply to the Comment on "Factors Affecting the Clinical Response to Desmopressin Treatment for Primary Monosymptomatic Nocturnal Enuresis in Children".

    Neurourology and urodynamics · October 26, 2026 · Editorial, letter or other · cited 0 times

    PMID 42935132 · DOI 10.1002/nau.70506 · Commentary and other

  4. Letter to the Editor on: "Factors Affecting the Clinical Response to Desmopressin Treatment for Primary Monosymptomatic Nocturnal Enuresis in Children".

    Neurourology and urodynamics · October 23, 2026 · Editorial, letter or other · cited 0 times

    PMID 42924449 · DOI 10.1002/nau.70498 · Commentary and other

  5. Letter to the Editor: "Factors Affecting the Clinical Response to Desmopressin Treatment for Primary Monosymptomatic Nocturnal Enuresis in Children".

    Neurourology and urodynamics · October 23, 2026 · Editorial, letter or other · cited 0 times

    PMID 42924467 · DOI 10.1002/nau.70503 · Commentary and other

  6. Evaluation of desmopressin in preventing overcorrection of hyponatraemia among patients with renal dysfunction.

    European journal of hospital pharmacy : science and practice · October 23, 2026 · Not yet classified · cited 0 times

    PMID 41475799 · DOI 10.1136/ejhpharm-2025-004693 · Not yet classified

  7. Use of Desmopressin in Spontaneous Nontraumatic Intracerebral Hemorrhage Among Patients Taking Antiplatelet Therapy: Systematic Review and Bayesian Meta-analysis.

    Neurocritical care · October 12, 2026 · Review · cited 0 times · open access

    PMID 42864513 · DOI 10.1007/s12028-026-02672-3 · Reviews and meta-analyses

  8. Acute Hemorrhagic Manifestations in a Pregnant Patient With Type 1 von Willebrand Disease: Challenges in Management of Bleeding Disorders During Gestation.

    Clinical case reports · October 11, 2026 · Case report · cited 0 times · open access

    PMID 42865846 · DOI 10.1002/ccr3.73728 · Human clinical research

  9. Copeptin and urine concentrating capacity predict kidney function decline in lithium-treated patients.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · October 8, 2026 · Observational human study · cited 0 times

    PMID 42847926 · DOI 10.1093/ndt/gfag219 · Human clinical research

  10. A Case of Misdiagnosed Pediatric Congenital Nephrogenic Diabetes Insipidus due to AQP2 Variants.

    Case reports in pediatrics · October 8, 2026 · Case report · cited 0 times · open access

    PMID 42852029 · DOI 10.1155/crpe/9068249 · Human clinical research

Browse all 3,764 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: 1-deamino-8-D-arginine vasopressin; DDAVP; Desmopresina; Desmopressin; Desmopressine; Desmotabs; Minirin; Nocdurna; Noctiva; Nocutil; Octim

((TITLE_ABS:"1-deamino-8-D-arginine vasopressin" OR CHEM:"1-deamino-8-D-arginine vasopressin" OR TITLE_ABS:"1-deamino8-D-arginine vasopressin" OR CHEM:"1-deamino8-D-arginine vasopressin") OR (TITLE_ABS:"DDAVP" OR CHEM:"DDAVP") OR (TITLE_ABS:"Desmopresina" OR CHEM:"Desmopresina") OR (TITLE_ABS:"Desmopressin" OR CHEM:"Desmopressin") OR (TITLE_ABS:"Desmopressine" OR CHEM:"Desmopressine") OR (TITLE_ABS:"Desmotabs" OR CHEM:"Desmotabs") OR (TITLE_ABS:"Minirin" OR CHEM:"Minirin") OR (TITLE_ABS:"Nocdurna" OR CHEM:"Nocdurna") OR (TITLE_ABS:"Noctiva" OR CHEM:"Noctiva") OR (TITLE_ABS:"Nocutil" OR CHEM:"Nocutil") OR (TITLE_ABS:"Octim" OR CHEM:"Octim")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 2). Desmopressin research statistics (Version weekly-2026-11-01) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/desmopressin